World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
24185
World Ranking
16645
National Ranking
8355

Michael P. LaQuaglia publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael P. LaQuaglia sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 371 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael P. LaQuaglia D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael P. LaQuaglia sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael P. LaQuaglia is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research spans multiple domains within medicine, biochemistry, genetics, and molecular biology, with notable contributions to neurology, pulmonary and respiratory medicine, surgery, molecular biology, and cancer research as subfields.

The primary topics addressed in LaQuaglia's work include:

  • Neuroblastoma Research and Treatments
  • Sarcoma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Cancer, Hypoxia, and Metabolism
  • Thyroid Cancer Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Protein Degradation and Inhibitors

The scientist has published extensively across several peer-reviewed venues, with frequent appearances in:

  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Pediatric Blood & Cancer
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)

Some of the recent papers authored or co-authored by Michael P. LaQuaglia include:

  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers, 2020, published in Cell
  • Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets, 2022, published in Nature Communications
  • Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol, 2021, published in Journal of Clinical Oncology
  • B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study, 2020, published in Journal of Clinical Oncology
  • A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing, 2020, published in Cancers

Frequent collaborators in LaQuaglia's research include:

  • Shakeel Modak
  • Todd E. Heaton
  • Neerav Shukla
  • Nai-Kong V. Cheung
  • Suzanne L. Wolden

Best Publications

  • Identification of ALK as a major familial neuroblastoma predisposition gene

    Yaël P. Mossé;Marci Laudenslager;Luca Longo;Kristina A. Cole

  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

    Ayuko Hoshino;Ayuko Hoshino;Han Sang Kim;Han Sang Kim;Linda Bojmar;Linda Bojmar;Linda Bojmar;Kofi Ennu Gyan

  • Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors

    Ute M. Moll;Michael Laquaglia;Jean Benard;Guy Riou

  • TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODY

    A. Cosimi;Robert Burton;Robert Colvin;Gideon Goldstein

  • Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma

    Joshua N. Honeyman;Joshua N. Honeyman;Elana P. Simon;Nicolas Robine;Rachel Chiaroni-Clarke

  • Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants.

    W L Gerald;M Ladanyi;E de Alava;M Cuatrecasas

  • Osteogenic sarcoma with clinically detectable metastasis at initial presentation.

    P. A. Meyers;G. Heller;J. H. Healey;A. Huvos

  • Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.

    B. H. Kushner;M. P. Laquaglia;N. Wollner;P. A. Meyers

  • Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.

    Sosipatros A. Boikos;Alberto S. Pappo;J. Keith Killian;Michael P. LaQuaglia

  • Results of multimodal treatment for desmoplastic small round cell tumors.

    Dave R. Lal;Wendy T. Su;Suzanne L. Wolden;Kenneth C. Loh

  • Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature.

    Sonam Prakash;Lisa Sarran;Nicholas Socci;Ronald P DeMatteo

  • A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene

    Kristina A. Cole;Edward F. Attiyeh;Yael P. Mosse;Michael J. Laquaglia

  • Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors

    Narasimhan P. Agaram;Michael P. Laquaglia;Berrin Ustun;Tianhua Guo

  • Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

    Susan G Kreissman;Robert C Seeger;Katherine K Matthay;Wendy B London;Wendy B London

  • Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group.

    Kurt D. Newman;Thomas Black;Glenn Heller;Richard G. Azizkhan

  • RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma

    Kristina A. Cole;Jonathan Huggins;Michael Laquaglia;Chase E. Hulderman

  • Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.

    Juan Miguel Mosquera;Andrea Sboner;Lei Zhang;Naoki Kitabayashi

  • Malignant pancreatic tumors in childhood and adolescence: The Memorial Sloan-Kettering experience, 1967 to present

    V. Nicholas A. Shorter;Richard D. Glick;David S. Klimstra;Murray F. Brennan

  • A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases.

    Rita Alaggio;Lei Zhang;Yun-Shao Sung;Shih-Chiang Huang

  • Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.

    B H Kushner;P A Meyers;W L Gerald;J H Healey

Frequent Co-Authors

Nai-Kong V. Cheung
Nai-Kong V. Cheung Memorial Sloan Kettering Cancer Center
Suzanne L. Wolden
Suzanne L. Wolden Memorial Sloan Kettering Cancer Center
Paul A. Meyers
Paul A. Meyers Memorial Sloan Kettering Cancer Center
William L. Gerald
William L. Gerald Memorial Sloan Kettering Cancer Center
John H. Healey
John H. Healey Memorial Sloan Kettering Cancer Center
Glenn Heller
Glenn Heller Memorial Sloan Kettering Cancer Center
Sanford M. Simon
Sanford M. Simon Rockefeller University
Cristina R. Antonescu
Cristina R. Antonescu Memorial Sloan Kettering Cancer Center
Marc Ladanyi
Marc Ladanyi Memorial Sloan Kettering Cancer Center
Andrew G. Huvos
Andrew G. Huvos Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering medical careers beyond a traditional MD, a wide variety of online nursing pathways can help you enter or advance in the healthcare field. Many prospective students are concerned about tuition costs, so exploring what is the cheapest online college for nursing? can be an important first step. Affordable options help reduce student debt and make career pivots more accessible.

For aspiring nurses who already have an RN and want to earn a bachelor’s degree, cheapest rn to bsn programs let you build credentials quickly and economically. Those who hold a non-nursing bachelor’s degree may consider msn direct entry programs online to transition efficiently into advanced practice nursing roles.

If you’re looking to move into academia, leadership, or research, online phd programs nursing offer flexible options for pursuing the highest level of nursing education. Whether you’re just starting or aiming for advanced positions, today’s online programs provide a wide range of clinical and non-clinical career pathways in healthcare.

Best Scientists Citing Michael P. LaQuaglia

Trending Scientists

Recently Published Articles